Daewon Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Daewon Pharmaceutical has a total shareholder equity of ₩289.7B and total debt of ₩184.9B, which brings its debt-to-equity ratio to 63.8%. Its total assets and total liabilities are ₩598.7B and ₩309.0B respectively. Daewon Pharmaceutical's EBIT is ₩31.1B making its interest coverage ratio 4.4. It has cash and short-term investments of ₩71.8B.
Key information
63.8%
Debt to equity ratio
₩184.89b
Debt
| Interest coverage ratio | 4.4x |
| Cash | ₩71.78b |
| Equity | ₩289.71b |
| Total liabilities | ₩308.98b |
| Total assets | ₩598.69b |
Recent financial health updates
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Aug 13
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Mar 26Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly
Dec 10
Recent updates
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Aug 13Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) 27% Jump Shows Its Popularity With Investors
Jul 17There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings
Mar 21Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Mar 26Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?
Mar 07Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?
Feb 18Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 31Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?
Jan 13Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend
Dec 24Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly
Dec 10Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?
Nov 22Financial Position Analysis
Short Term Liabilities: A003220's short term assets (₩264.2B) exceed its short term liabilities (₩208.8B).
Long Term Liabilities: A003220's short term assets (₩264.2B) exceed its long term liabilities (₩100.2B).
Debt to Equity History and Analysis
Debt Level: A003220's net debt to equity ratio (39%) is considered satisfactory.
Reducing Debt: A003220's debt to equity ratio has increased from 23.9% to 63.8% over the past 5 years.
Debt Coverage: A003220's debt is not well covered by operating cash flow (13%).
Interest Coverage: A003220's interest payments on its debt are well covered by EBIT (4.4x coverage).